| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | integrin binding | 4.89e-06 | 175 | 29 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 2.62e-05 | 120 | 29 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | glycosphingolipid binding | 1.57e-04 | 13 | 29 | 2 | GO:0043208 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.91e-04 | 200 | 29 | 4 | GO:0008237 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 2.15e-04 | 1189 | 29 | 8 | GO:0046914 | |
| GeneOntologyMolecularFunction | zinc ion binding | 2.27e-04 | 891 | 29 | 7 | GO:0008270 | |
| GeneOntologyMolecularFunction | diacylglycerol binding | 2.41e-04 | 16 | 29 | 2 | GO:0019992 | |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 2.41e-04 | 16 | 29 | 2 | GO:0004697 | |
| GeneOntologyMolecularFunction | calcium ion binding | 6.19e-04 | 749 | 29 | 6 | GO:0005509 | |
| GeneOntologyMolecularFunction | sphingolipid binding | 1.11e-03 | 34 | 29 | 2 | GO:0046625 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.56e-03 | 599 | 29 | 5 | GO:0050839 | |
| GeneOntologyMolecularFunction | peptidase activity | 2.29e-03 | 654 | 29 | 5 | GO:0008233 | |
| GeneOntologyMolecularFunction | glycolipid binding | 2.30e-03 | 49 | 29 | 2 | GO:0051861 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.51e-03 | 188 | 29 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 3.29e-03 | 430 | 29 | 4 | GO:0004175 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 3.29e-03 | 207 | 29 | 3 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 3.52e-03 | 212 | 29 | 3 | GO:0017171 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 4.47e-03 | 231 | 29 | 3 | GO:0005085 | |
| GeneOntologyBiologicalProcess | axon guidance | 2.40e-06 | 285 | 29 | 6 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 2.45e-06 | 286 | 29 | 6 | GO:0097485 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 4.34e-06 | 23 | 29 | 3 | GO:2001044 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.04e-05 | 566 | 29 | 7 | GO:0007409 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.05e-05 | 802 | 29 | 8 | GO:0048812 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 1.22e-05 | 819 | 29 | 8 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 1.30e-05 | 826 | 29 | 8 | GO:0048858 | |
| GeneOntologyBiologicalProcess | axon development | 2.35e-05 | 642 | 29 | 7 | GO:0061564 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 2.47e-05 | 1194 | 29 | 9 | GO:0000902 | |
| GeneOntologyBiologicalProcess | neuron projection development | 4.41e-05 | 1285 | 29 | 9 | GO:0031175 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | 5.68e-05 | 1327 | 29 | 9 | GO:0040012 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 6.23e-05 | 748 | 29 | 7 | GO:0048667 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 1.04e-04 | 11 | 29 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | neuron development | 1.21e-04 | 1463 | 29 | 9 | GO:0048666 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation in thymus | 1.47e-04 | 13 | 29 | 2 | GO:0033089 | |
| GeneOntologyBiologicalProcess | constitutive heterochromatin formation | 1.47e-04 | 13 | 29 | 2 | GO:0140719 | |
| GeneOntologyBiologicalProcess | cell recognition | 1.62e-04 | 198 | 29 | 4 | GO:0008037 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.72e-04 | 14 | 29 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 2.21e-04 | 84 | 29 | 3 | GO:1903053 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | 2.85e-04 | 1280 | 29 | 8 | GO:2000145 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 4.37e-04 | 106 | 29 | 3 | GO:0051149 | |
| GeneOntologyBiologicalProcess | positive regulation of response to external stimulus | 4.83e-04 | 738 | 29 | 6 | GO:0032103 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | 4.97e-04 | 742 | 29 | 6 | GO:0040017 | |
| GeneOntologyBiologicalProcess | T cell differentiation in thymus | 5.41e-04 | 114 | 29 | 3 | GO:0033077 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 6.91e-04 | 124 | 29 | 3 | GO:0007229 | |
| GeneOntologyBiologicalProcess | neuron projection fasciculation | 7.05e-04 | 28 | 29 | 2 | GO:0106030 | |
| GeneOntologyBiologicalProcess | axonal fasciculation | 7.05e-04 | 28 | 29 | 2 | GO:0007413 | |
| GeneOntologyBiologicalProcess | Ras protein signal transduction | 7.58e-04 | 128 | 29 | 3 | GO:0007265 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 8.29e-04 | 1141 | 29 | 7 | GO:0045597 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor superfamily cytokine production | 9.23e-04 | 137 | 29 | 3 | GO:1903557 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | 1.15e-03 | 577 | 29 | 5 | GO:0001667 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | 1.18e-03 | 1211 | 29 | 7 | GO:0030334 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 1.23e-03 | 37 | 29 | 2 | GO:0033081 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell migration | 1.51e-03 | 41 | 29 | 2 | GO:2000406 | |
| GeneOntologyBiologicalProcess | epithelial tube branching involved in lung morphogenesis | 1.51e-03 | 41 | 29 | 2 | GO:0060441 | |
| GeneOntologyBiologicalProcess | positive regulation of chemotaxis | 1.60e-03 | 166 | 29 | 3 | GO:0050921 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 1.66e-03 | 43 | 29 | 2 | GO:0071711 | |
| GeneOntologyBiologicalProcess | male gonad development | 1.75e-03 | 171 | 29 | 3 | GO:0008584 | |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 1.78e-03 | 172 | 29 | 3 | GO:0046546 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.82e-03 | 377 | 29 | 4 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.84e-03 | 378 | 29 | 4 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.85e-03 | 379 | 29 | 4 | GO:0045229 | |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | 1.91e-03 | 1316 | 29 | 7 | GO:0032101 | |
| GeneOntologyBiologicalProcess | forelimb morphogenesis | 2.07e-03 | 48 | 29 | 2 | GO:0035136 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte migration | 2.15e-03 | 49 | 29 | 2 | GO:2000403 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 2.18e-03 | 185 | 29 | 3 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 2.18e-03 | 185 | 29 | 3 | GO:0035108 | |
| GeneOntologyBiologicalProcess | binding of sperm to zona pellucida | 2.42e-03 | 52 | 29 | 2 | GO:0007339 | |
| GeneOntologyBiologicalProcess | lymphocyte chemotaxis | 2.52e-03 | 53 | 29 | 2 | GO:0048247 | |
| GeneOntologyBiologicalProcess | membrane protein ectodomain proteolysis | 2.52e-03 | 53 | 29 | 2 | GO:0006509 | |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | 2.53e-03 | 691 | 29 | 5 | GO:0030335 | |
| GeneOntologyBiologicalProcess | male sex differentiation | 2.69e-03 | 199 | 29 | 3 | GO:0046661 | |
| GeneOntologyBiologicalProcess | blood vessel endothelial cell migration | 2.69e-03 | 199 | 29 | 3 | GO:0043534 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 2.69e-03 | 199 | 29 | 3 | GO:0051147 | |
| GeneOntologyBiologicalProcess | positive regulation of innate immune response | 2.69e-03 | 420 | 29 | 4 | GO:0045089 | |
| GeneOntologyBiologicalProcess | tube development | 2.74e-03 | 1402 | 29 | 7 | GO:0035295 | |
| GeneOntologyBiologicalProcess | regulation of T cell migration | 2.80e-03 | 56 | 29 | 2 | GO:2000404 | |
| GeneOntologyCellularComponent | laminin complex | 3.18e-07 | 10 | 30 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | laminin-2 complex | 1.99e-06 | 2 | 30 | 2 | GO:0005607 | |
| GeneOntologyCellularComponent | laminin-1 complex | 5.97e-06 | 3 | 30 | 2 | GO:0005606 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 2.67e-04 | 17 | 30 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | basement membrane | 7.02e-04 | 122 | 30 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 3.24e-03 | 59 | 30 | 2 | GO:0098636 | |
| Domain | EGF_LAM_2 | 8.70e-10 | 30 | 29 | 5 | PS50027 | |
| Domain | EGF_LAM_1 | 8.70e-10 | 30 | 29 | 5 | PS01248 | |
| Domain | Laminin_EGF | 1.97e-09 | 35 | 29 | 5 | PF00053 | |
| Domain | EGF_Lam | 1.97e-09 | 35 | 29 | 5 | SM00180 | |
| Domain | Laminin_EGF | 3.04e-09 | 38 | 29 | 5 | IPR002049 | |
| Domain | EGF_1 | 3.62e-09 | 255 | 29 | 8 | PS00022 | |
| Domain | EGF-like_CS | 4.35e-09 | 261 | 29 | 8 | IPR013032 | |
| Domain | EGF_2 | 4.90e-09 | 265 | 29 | 8 | PS01186 | |
| Domain | - | 2.23e-08 | 20 | 29 | 4 | 4.10.70.10 | |
| Domain | C1_1 | 2.48e-08 | 57 | 29 | 5 | PF00130 | |
| Domain | DISIN | 2.75e-08 | 21 | 29 | 4 | SM00050 | |
| Domain | Disintegrin | 2.75e-08 | 21 | 29 | 4 | PF00200 | |
| Domain | ZF_DAG_PE_1 | 4.49e-08 | 64 | 29 | 5 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 4.49e-08 | 64 | 29 | 5 | PS50081 | |
| Domain | C1 | 4.86e-08 | 65 | 29 | 5 | SM00109 | |
| Domain | PE/DAG-bd | 5.25e-08 | 66 | 29 | 5 | IPR002219 | |
| Domain | EGF-like_dom | 8.36e-08 | 249 | 29 | 7 | IPR000742 | |
| Domain | Peptidase_M12B_N | 3.71e-07 | 39 | 29 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 3.71e-07 | 39 | 29 | 4 | PF01562 | |
| Domain | DISINTEGRIN_1 | 4.12e-07 | 40 | 29 | 4 | PS00427 | |
| Domain | ADAM_MEPRO | 4.12e-07 | 40 | 29 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 4.12e-07 | 40 | 29 | 4 | PS50214 | |
| Domain | Reprolysin | 4.12e-07 | 40 | 29 | 4 | PF01421 | |
| Domain | Peptidase_M12B | 4.12e-07 | 40 | 29 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 4.56e-07 | 41 | 29 | 4 | IPR001762 | |
| Domain | EGF | 1.39e-06 | 235 | 29 | 6 | SM00181 | |
| Domain | Disintegrin_CS | 1.86e-06 | 16 | 29 | 3 | IPR018358 | |
| Domain | ADAM_CR | 2.70e-06 | 18 | 29 | 3 | PF08516 | |
| Domain | DAG/PE-bd | 4.39e-06 | 21 | 29 | 3 | IPR020454 | |
| Domain | Protein_Kinase_C_mu-related | 6.98e-06 | 3 | 29 | 2 | IPR015727 | |
| Domain | MetalloPept_cat_dom | 7.18e-06 | 81 | 29 | 4 | IPR024079 | |
| Domain | - | 7.18e-06 | 81 | 29 | 4 | 3.40.390.10 | |
| Domain | ADAM_Cys-rich | 9.60e-06 | 27 | 29 | 3 | IPR006586 | |
| Domain | ACR | 9.60e-06 | 27 | 29 | 3 | SM00608 | |
| Domain | EGF_3 | 2.80e-05 | 235 | 29 | 5 | PS50026 | |
| Domain | LAMININ_IVA | 6.48e-05 | 8 | 29 | 2 | PS51115 | |
| Domain | Laminin_B | 6.48e-05 | 8 | 29 | 2 | PF00052 | |
| Domain | LamB | 6.48e-05 | 8 | 29 | 2 | SM00281 | |
| Domain | Laminin_IV | 6.48e-05 | 8 | 29 | 2 | IPR000034 | |
| Domain | Growth_fac_rcpt_ | 9.45e-05 | 156 | 29 | 4 | IPR009030 | |
| Domain | LAMININ_NTER | 2.76e-04 | 16 | 29 | 2 | PS51117 | |
| Domain | Laminin_N | 2.76e-04 | 16 | 29 | 2 | PF00055 | |
| Domain | Laminin_N | 2.76e-04 | 16 | 29 | 2 | IPR008211 | |
| Domain | LamNT | 2.76e-04 | 16 | 29 | 2 | SM00136 | |
| Domain | RasGEFN | 4.35e-04 | 20 | 29 | 2 | SM00229 | |
| Domain | RasGEF_N | 4.80e-04 | 21 | 29 | 2 | PF00618 | |
| Domain | RASGEF_NTER | 5.27e-04 | 22 | 29 | 2 | PS50212 | |
| Domain | Ras-like_Gua-exchang_fac_N | 5.27e-04 | 22 | 29 | 2 | IPR000651 | |
| Domain | - | 5.79e-04 | 449 | 29 | 5 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 6.40e-04 | 459 | 29 | 5 | IPR013083 | |
| Domain | RASGEF | 7.39e-04 | 26 | 29 | 2 | PS00720 | |
| Domain | RASGEF_CAT | 9.21e-04 | 29 | 29 | 2 | PS50009 | |
| Domain | RasGEF | 9.86e-04 | 30 | 29 | 2 | PF00617 | |
| Domain | - | 9.86e-04 | 30 | 29 | 2 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 9.86e-04 | 30 | 29 | 2 | IPR023578 | |
| Domain | RASGEF_cat_dom | 9.86e-04 | 30 | 29 | 2 | IPR001895 | |
| Domain | RasGEF | 9.86e-04 | 30 | 29 | 2 | SM00147 | |
| Domain | Znf_FYVE_PHD | 1.50e-03 | 147 | 29 | 3 | IPR011011 | |
| Domain | Znf_RING | 1.53e-03 | 326 | 29 | 4 | IPR001841 | |
| Domain | LAM_G_DOMAIN | 1.58e-03 | 38 | 29 | 2 | PS50025 | |
| Domain | Laminin_G_2 | 1.75e-03 | 40 | 29 | 2 | PF02210 | |
| Domain | LamG | 2.11e-03 | 44 | 29 | 2 | SM00282 | |
| Domain | Laminin_G | 3.65e-03 | 58 | 29 | 2 | IPR001791 | |
| Domain | EGF_extracell | 3.90e-03 | 60 | 29 | 2 | IPR013111 | |
| Domain | EGF_2 | 3.90e-03 | 60 | 29 | 2 | PF07974 | |
| Domain | Zinc_finger_PHD-type_CS | 4.56e-03 | 65 | 29 | 2 | IPR019786 | |
| Domain | PH | 8.96e-03 | 278 | 29 | 3 | SM00233 | |
| Domain | PH_DOMAIN | 9.04e-03 | 279 | 29 | 3 | PS50003 | |
| Domain | PH_domain | 9.13e-03 | 280 | 29 | 3 | IPR001849 | |
| Domain | Galactose-bd-like | 9.31e-03 | 94 | 29 | 2 | IPR008979 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 5.40e-07 | 11 | 22 | 3 | M158 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.30e-05 | 30 | 22 | 3 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.30e-05 | 30 | 22 | 3 | M27216 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.75e-05 | 33 | 22 | 3 | M39503 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.38e-05 | 41 | 22 | 3 | M27778 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 4.79e-05 | 46 | 22 | 3 | M239 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.93e-05 | 140 | 22 | 4 | M587 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.26e-05 | 300 | 22 | 5 | M610 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.01e-04 | 59 | 22 | 3 | M27218 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 1.42e-04 | 66 | 22 | 3 | MM15925 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.42e-04 | 66 | 22 | 3 | M18 | |
| Pathway | BIOCARTA_PRION_PATHWAY | 1.52e-04 | 12 | 22 | 2 | M22020 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 2.41e-04 | 15 | 22 | 2 | MM15019 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY | 2.41e-04 | 15 | 22 | 2 | M47816 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.42e-04 | 79 | 22 | 3 | M27643 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 2.75e-04 | 16 | 22 | 2 | M923 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.90e-04 | 84 | 22 | 3 | M3228 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.90e-04 | 84 | 22 | 3 | M7098 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 4.29e-04 | 96 | 22 | 3 | M39834 | |
| Pathway | PID_INTEGRIN_A9B1_PATHWAY | 6.82e-04 | 25 | 22 | 2 | M118 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 7.97e-04 | 27 | 22 | 2 | M12123 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 7.97e-04 | 27 | 22 | 2 | M760 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 8.57e-04 | 28 | 22 | 2 | MM14958 | |
| Pathway | WP_CANCER_PATHWAYS | 9.35e-04 | 507 | 22 | 5 | M48302 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 9.85e-04 | 30 | 22 | 2 | MM15812 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 9.85e-04 | 30 | 22 | 2 | M39641 | |
| Pathway | PID_RAS_PATHWAY | 9.85e-04 | 30 | 22 | 2 | M269 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.16e-03 | 532 | 22 | 5 | M27870 | |
| Pathway | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | 1.50e-03 | 37 | 22 | 2 | M554 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 1.58e-03 | 38 | 22 | 2 | MM15456 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 1.66e-03 | 39 | 22 | 2 | M10735 | |
| Pathway | WP_RAS_SIGNALING | 2.81e-03 | 184 | 22 | 3 | M39764 | |
| Pathway | WP_FOCAL_ADHESION | 2.94e-03 | 187 | 22 | 3 | MM15913 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 3.05e-03 | 53 | 22 | 2 | M27039 | |
| Pathway | PID_CD8_TCR_PATHWAY | 3.05e-03 | 53 | 22 | 2 | M88 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.50e-03 | 199 | 22 | 3 | M7253 | |
| Pathway | WP_FOCAL_ADHESION | 3.50e-03 | 199 | 22 | 3 | M39402 | |
| Pathway | PID_TCR_PATHWAY | 4.42e-03 | 64 | 22 | 2 | M34 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.18e-03 | 76 | 22 | 2 | M27219 | |
| Pubmed | 5.78e-09 | 5 | 30 | 3 | 9719032 | ||
| Pubmed | Expression and localization of laminin-5 subunits in the mouse incisor. | 1.16e-08 | 6 | 30 | 3 | 9506922 | |
| Pubmed | 3.23e-08 | 8 | 30 | 3 | 8872465 | ||
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 3.23e-08 | 8 | 30 | 3 | 9489770 | |
| Pubmed | 6.92e-08 | 10 | 30 | 3 | 9034910 | ||
| Pubmed | 6.92e-08 | 10 | 30 | 3 | 11784026 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 9.51e-08 | 11 | 30 | 3 | 21524702 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 9.51e-08 | 11 | 30 | 3 | 23472759 | |
| Pubmed | 1.27e-07 | 12 | 30 | 3 | 9396756 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 2.62e-07 | 15 | 30 | 3 | 12921739 | |
| Pubmed | 2.62e-07 | 15 | 30 | 3 | 9264260 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 2.62e-07 | 15 | 30 | 3 | 15895400 | |
| Pubmed | 3.22e-07 | 16 | 30 | 3 | 17601529 | ||
| Pubmed | 4.68e-07 | 18 | 30 | 3 | 11311202 | ||
| Pubmed | 4.68e-07 | 18 | 30 | 3 | 14730302 | ||
| Pubmed | 6.54e-07 | 20 | 30 | 3 | 22911573 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 16631359 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20220092 | ||
| Pubmed | Laminin terminates the Netrin/DCC mediated attraction of vagal sensory axons. | 7.19e-07 | 2 | 30 | 2 | 18418846 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 10842354 | ||
| Pubmed | ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. | 1.32e-06 | 25 | 30 | 3 | 17170699 | |
| Pubmed | 1.49e-06 | 26 | 30 | 3 | 24742657 | ||
| Pubmed | 2.08e-06 | 29 | 30 | 3 | 22613833 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 2100263 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 1907584 | ||
| Pubmed | Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer. | 2.16e-06 | 3 | 30 | 2 | 26253275 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 1292752 | ||
| Pubmed | Expression of the protein kinase D (PKD) family during mouse embryogenesis. | 2.16e-06 | 3 | 30 | 2 | 16377259 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 7669546 | ||
| Pubmed | Three-dimensional analysis of the developing pituitary gland in the mouse. | 2.16e-06 | 3 | 30 | 2 | 9603432 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 12817022 | ||
| Pubmed | An association of IgG anti-laminin-1 autoantibodies with endometriosis in infertile patients. | 2.16e-06 | 3 | 30 | 2 | 12615822 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 27662904 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 32747433 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 26426580 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 20621130 | ||
| Pubmed | Differential expression of laminin A and B chains during development of embryonic mouse organs. | 2.16e-06 | 3 | 30 | 2 | 2088723 | |
| Pubmed | Effect of deletion of the protein kinase PRKD1 on development of the mouse embryonic heart. | 2.16e-06 | 3 | 30 | 2 | 38419169 | |
| Pubmed | Expression of laminin chains by central neurons: analysis with gene and protein trapping techniques. | 4.31e-06 | 4 | 30 | 2 | 12820173 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 2099832 | ||
| Pubmed | A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein. | 4.31e-06 | 4 | 30 | 2 | 24247244 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 14761956 | ||
| Pubmed | Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network. | 4.31e-06 | 4 | 30 | 2 | 14743217 | |
| Pubmed | CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. | 4.31e-06 | 4 | 30 | 2 | 15334074 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 10433800 | ||
| Pubmed | Role of mesenchymal nidogen for epithelial morphogenesis in vitro. | 4.31e-06 | 4 | 30 | 2 | 7925005 | |
| Pubmed | Role of laminin terminal globular domains in basement membrane assembly. | 4.31e-06 | 4 | 30 | 2 | 17517882 | |
| Pubmed | Laminin-1 reexpression in Alport mouse glomerular basement membranes. | 4.31e-06 | 4 | 30 | 2 | 12631063 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 9299121 | ||
| Pubmed | New pUC-derived expression vectors for rapid construction of cDNA libraries. | 4.31e-06 | 4 | 30 | 2 | 2436975 | |
| Pubmed | Laminin-111 restores regenerative capacity in a mouse model for alpha7 integrin congenital myopathy. | 4.31e-06 | 4 | 30 | 2 | 19074617 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 9885251 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 10801807 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 9201115 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 8034675 | ||
| Pubmed | Depletion of nuclear actin is a key mediator of quiescence in epithelial cells. | 4.31e-06 | 4 | 30 | 2 | 21172822 | |
| Pubmed | 5.60e-06 | 40 | 30 | 3 | 27068110 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 1725162 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 8286607 | ||
| Pubmed | A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. | 7.18e-06 | 5 | 30 | 2 | 9789079 | |
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 8359228 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 7516699 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 19416897 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 18172297 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 10964500 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 9647658 | ||
| Pubmed | Laminin alpha 2 chain (M chain) is found within the pathway of avian and murine retinal projections. | 7.18e-06 | 5 | 30 | 2 | 8613743 | |
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 7544312 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 12743034 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 7851641 | ||
| Pubmed | Localization of the 110 kDa receptor for laminin in brains of embryonic and postnatal mice. | 7.18e-06 | 5 | 30 | 2 | 7895274 | |
| Pubmed | Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. | 7.18e-06 | 5 | 30 | 2 | 8719886 | |
| Pubmed | Protein kinase D regulates RhoA activity via rhotekin phosphorylation. | 7.18e-06 | 5 | 30 | 2 | 22228765 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 1678389 | ||
| Pubmed | Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution. | 1.08e-05 | 6 | 30 | 2 | 23948589 | |
| Pubmed | Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth. | 1.08e-05 | 6 | 30 | 2 | 19118221 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 2119632 | ||
| Pubmed | Genetic mapping of mouse tumor necrosis factor-alpha converting enzyme (TACE) to chromosome 12. | 1.08e-05 | 6 | 30 | 2 | 9598327 | |
| Pubmed | Ethanol increases fetal human neurosphere size and alters adhesion molecule gene expression. | 1.08e-05 | 6 | 30 | 2 | 18162078 | |
| Pubmed | Expression and role of laminin-1 in mouse pancreatic organogenesis. | 1.08e-05 | 6 | 30 | 2 | 10866045 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 26555376 | ||
| Pubmed | Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets. | 1.08e-05 | 6 | 30 | 2 | 29925524 | |
| Pubmed | Effect of basement membrane entactin on epidermal cell attachment and growth. | 1.08e-05 | 6 | 30 | 2 | 3794389 | |
| Pubmed | Shedding of collagen XVII/BP180 in skin depends on both ADAM10 and ADAM9. | 1.08e-05 | 6 | 30 | 2 | 19574220 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 20874775 | ||
| Pubmed | Laminin-nidogen complex. Extraction with chelating agents and structural characterization. | 1.08e-05 | 6 | 30 | 2 | 3109910 | |
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 8276400 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 7921537 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 14557481 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 15907280 | ||
| Pubmed | Abscence of laminin alpha1 chain in the skeletal muscle of dystrophic dy/dy mice. | 1.51e-05 | 7 | 30 | 2 | 9390664 | |
| Pubmed | Multiple roles of Rap1 in hematopoietic cells: complementary versus antagonistic functions. | 1.51e-05 | 7 | 30 | 2 | 16076873 | |
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 8722691 | ||
| Pubmed | 2.01e-05 | 8 | 30 | 2 | 23091646 | ||
| Pubmed | 2.01e-05 | 8 | 30 | 2 | 12015298 | ||
| Pubmed | Mouse kalinin B1 (laminin beta 3 chain): cloning and tissue distribution. | 2.01e-05 | 8 | 30 | 2 | 7898049 | |
| Pubmed | 2.01e-05 | 8 | 30 | 2 | 8812145 | ||
| Pubmed | 2.01e-05 | 8 | 30 | 2 | 8725284 | ||
| Pubmed | Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. | 2.01e-05 | 8 | 30 | 2 | 23529140 | |
| Pubmed | 2.01e-05 | 8 | 30 | 2 | 17344430 | ||
| Interaction | ADAM12 interactions | 1.39e-06 | 58 | 29 | 4 | int:ADAM12 | |
| Interaction | FBXO2 interactions | 2.21e-05 | 411 | 29 | 6 | int:FBXO2 | |
| Interaction | PSG8 interactions | 2.75e-05 | 41 | 29 | 3 | int:PSG8 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q36 | 1.42e-03 | 85 | 30 | 2 | chr2q36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p11 | 2.08e-03 | 103 | 30 | 2 | chr8p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q12 | 2.16e-03 | 105 | 30 | 2 | chr14q12 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.32e-08 | 27 | 21 | 4 | 47 | |
| GeneFamily | Laminin subunits | 2.95e-07 | 12 | 21 | 3 | 626 | |
| Coexpression | GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP | 2.52e-06 | 200 | 29 | 5 | M3425 | |
| Coexpression | NABA_MATRISOME | 9.72e-06 | 1008 | 29 | 8 | MM17056 | |
| Coexpression | NABA_MATRISOME | 1.11e-05 | 1026 | 29 | 8 | M5889 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.17e-05 | 40 | 29 | 3 | M5887 | |
| Coexpression | HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP | 4.41e-05 | 62 | 29 | 3 | M6176 | |
| Coexpression | WEBER_METHYLATED_ICP_IN_SPERM_DN | 9.15e-05 | 13 | 29 | 2 | M16399 | |
| Coexpression | NABA_ECM_REGULATORS | 1.32e-04 | 238 | 29 | 4 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 1.40e-04 | 242 | 29 | 4 | MM17062 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 1.70e-04 | 482 | 29 | 5 | M12144 | |
| Coexpression | QI_PLASMACYTOMA_DN | 1.73e-04 | 98 | 29 | 3 | M1852 | |
| Coexpression | QI_PLASMACYTOMA_DN | 1.83e-04 | 100 | 29 | 3 | MM775 | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell-epi_progenitor|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.81e-06 | 183 | 29 | 4 | 031b4ffd95114dc10d2932c67d2cfef139b3fd2e | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 7.62e-06 | 196 | 29 | 4 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 8.25e-06 | 200 | 29 | 4 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.15e-04 | 146 | 29 | 3 | 159dd157a74f3c27dc1a1dcbbf0ed8f9462cac9e | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 150 | 29 | 3 | 6e806a028c0519489151c181d9907e05289e27e0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 162 | 29 | 3 | 9f568836199a05f696294caac1ea3fa413984423 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 167 | 29 | 3 | 3e3d8f6df2feefafad5b44ba0ebf5b5a0fe4ed58 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 167 | 29 | 3 | 3ad9f3122dbe96580f640388ef920ea209fc2349 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 172 | 29 | 3 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 172 | 29 | 3 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-04 | 176 | 29 | 3 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_LINC00507_CTXN3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-04 | 177 | 29 | 3 | 96d639407f79669f3990138793d157b94273581c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-04 | 177 | 29 | 3 | 921783ed0fe20294d2f384d9136924b679df01bb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-04 | 178 | 29 | 3 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.10e-04 | 179 | 29 | 3 | 56db12467b445f2b8ef92af50779eeab10413eb2 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.17e-04 | 181 | 29 | 3 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-04 | 182 | 29 | 3 | cc6f9d606a4f8717dc44928ceec2a257636043fd | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.20e-04 | 182 | 29 | 3 | 204530444e35d4977a7239ac176f477e9e5c29ab | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 2.31e-04 | 185 | 29 | 3 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 186 | 29 | 3 | e3a14f3ccadbf3211822c67b8956ee01f563307a | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.35e-04 | 186 | 29 | 3 | db9b67066fc003c7995ec205d15176bf40c97add | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-04 | 186 | 29 | 3 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 187 | 29 | 3 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.38e-04 | 187 | 29 | 3 | ab6f4d387218b4651fdadbf269806c1ddc96a1d2 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 187 | 29 | 3 | e6afbaed352310a1cb49571a2aae18be1f533c9a | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 187 | 29 | 3 | b6ecf55014f246461bf1ca12f24cb4d046661fa4 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 187 | 29 | 3 | 9fb15f24b9b364b0c4704ec98aec236eaec5411c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 188 | 29 | 3 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-NK-Intermediate_NK|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.42e-04 | 188 | 29 | 3 | a8170e4ce6406af9f5ad5317e6e26efa7bc66411 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-04 | 189 | 29 | 3 | 3f5522be3e24dcdb6272f18cee2f239dfdeff9ad | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 189 | 29 | 3 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 2.46e-04 | 189 | 29 | 3 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.46e-04 | 189 | 29 | 3 | ca3a04c202afc32aa11d17154066ef7dc6d01405 | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-NK|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.50e-04 | 190 | 29 | 3 | 86b0d142b7d1a3b35580edd104f947106be2c9c6 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.50e-04 | 190 | 29 | 3 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 2.50e-04 | 190 | 29 | 3 | 9fc763d65470ba8858b973689c4d4358faab7dd3 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-04 | 190 | 29 | 3 | 7e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.50e-04 | 190 | 29 | 3 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-04 | 190 | 29 | 3 | 1004e89d99c9d46c78b7d3532d8d4aadb81a96fd | |
| ToppCell | 18-Airway-Immune-Immune|Airway / Age, Tissue, Lineage and Cell class | 2.50e-04 | 190 | 29 | 3 | 09e6bbe4f1be48153dc6cd647a57a0b531b8bf99 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.50e-04 | 190 | 29 | 3 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-04 | 190 | 29 | 3 | 7fec459cd2ad12c2923a03d098289337c0a4c1d3 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-04 | 190 | 29 | 3 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-04 | 190 | 29 | 3 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | E15.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.54e-04 | 191 | 29 | 3 | 6f5d91a9583bbb30dfaa30dd9c7772995a9196be | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM3|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.54e-04 | 191 | 29 | 3 | 05867b96199a46a415848409130697c810d18937 | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.54e-04 | 191 | 29 | 3 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.54e-04 | 191 | 29 | 3 | 4c4f50a502e3f6768a89df686fa2830b83b8b33f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-04 | 191 | 29 | 3 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 2.54e-04 | 191 | 29 | 3 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.54e-04 | 191 | 29 | 3 | de7c88bb46f794291025ef121a89fcd94dea4ffe | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.54e-04 | 191 | 29 | 3 | 2b10a73c5d80e83d67a7121fb004a1aa86a537ef | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.54e-04 | 191 | 29 | 3 | 02e1ae144da7274171e055356d10e8d175c5347f | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.54e-04 | 191 | 29 | 3 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.58e-04 | 192 | 29 | 3 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | E15.5-Epithelial-epithelial_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.58e-04 | 192 | 29 | 3 | cb6f42dcffe650f7958543531d8f5412b2f2eb12 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.58e-04 | 192 | 29 | 3 | 063e119c4b58957643908f667e6cfd6f7517fd03 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.58e-04 | 192 | 29 | 3 | 158cc5736f154da1cb3186ffbf186eae10483e48 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.58e-04 | 192 | 29 | 3 | 39804d9ddc67c1b41887752df2503389eae44a1a | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.58e-04 | 192 | 29 | 3 | 34505a13b8a47c9286c560122fa7861b9c331a08 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.58e-04 | 192 | 29 | 3 | 57c1410ebf90c230993e065eb78385daa3360960 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.58e-04 | 192 | 29 | 3 | f4ff62ac9c53eafbe917706de9af8b2d4bded4d4 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-04 | 194 | 29 | 3 | 5bd0f739aa75f387cca7c3b2686493ee2d1ee968 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 194 | 29 | 3 | 415801a3dfacf05f2b603fb424df3d045190a812 | |
| ToppCell | COVID-19-Myeloid-TRAM2|Myeloid / Condition, Lineage and Cell class | 2.66e-04 | 194 | 29 | 3 | 4060a60c0271e7397b07993a1ef47b3291bba6e3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-04 | 194 | 29 | 3 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-04 | 194 | 29 | 3 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | COVID-19-lung-NK_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.66e-04 | 194 | 29 | 3 | 4c92f18e0a34fb50630d4b260eaf179202508b6d | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 194 | 29 | 3 | 256cb33ec90328f2704921fb0fe0fd9812e138b0 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 194 | 29 | 3 | 7942bc83c1bdca687795b91aa232824d603f9b09 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.70e-04 | 195 | 29 | 3 | 7a32a8535c29b819dacba901d0658280a2631c94 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.70e-04 | 195 | 29 | 3 | 4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 2.70e-04 | 195 | 29 | 3 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | COVID-19-lung-NK_cells|lung / Disease (COVID-19 only), tissue and cell type | 2.70e-04 | 195 | 29 | 3 | 3b716ec7acc9a37af6bf40e711a539ce58d74aa4 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.74e-04 | 196 | 29 | 3 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-04 | 196 | 29 | 3 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-04 | 196 | 29 | 3 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.74e-04 | 196 | 29 | 3 | 0a34a0009f479384f1994c6f977f942699a132c8 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-04 | 197 | 29 | 3 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | Mild|World / Condition, Lineage, Cell class and cell subclass | 2.78e-04 | 197 | 29 | 3 | 476b0d0389f9fcd4614f6bb1f494281f467f6730 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.86e-04 | 199 | 29 | 3 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-04 | 199 | 29 | 3 | dfb89ff7b075420c63ead0f802d93a5f82fb7c28 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.86e-04 | 199 | 29 | 3 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_CTL|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-04 | 199 | 29 | 3 | 7c63c389c914f1ef2fa92fa153f9ecf1087b8e31 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.86e-04 | 199 | 29 | 3 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | 993b0856964d611af8d8cd1ea4d609fa3ede65ea | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.90e-04 | 200 | 29 | 3 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 7668ae7ed550583ab59e419c5c9bb9f2d7e8e0d5 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD3-NKT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | 846d3f0e647040d0e372df0dfcd69a21d5da5aea | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)----L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 44f0278cb0e4ffcda4af3719d7f5819a10929b9f | |
| ToppCell | Control-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class | 2.90e-04 | 200 | 29 | 3 | 10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | 2efea0f2ac28d973182763d7667614204718d624 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD3|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | c70f06b243ae9804f97308ee02b4b5e1a4a6f9f3 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD3-NKT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | e9e1bd27d0ac3619c3a09e168a886cfd20e874b2 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD3|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | 06bd16ce6592e5afb8c2741687d98482faa55f4d | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)---|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 23da7790e09575b2ca909ed16806b44223bf1017 | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 91f3df1c5a661ff703835f58a35cee93f18eb15c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_CTL|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | 641c875ab1403e02d5d47a6f645d27273c2ee056 | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 2e2b1d252972b702ade25526ec8461bf613d81b0 | |
| Computational | Genes in the cancer module 493. | 1.61e-04 | 69 | 17 | 3 | MODULE_493 | |
| Drug | AC1L1B58 | 2.71e-10 | 29 | 29 | 5 | CID000001288 | |
| Drug | H-9 dihydrochloride | 9.50e-08 | 90 | 29 | 5 | CID000003544 | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 1.01e-07 | 183 | 29 | 6 | 7088_DN | |
| Drug | AC1L1G72 | 3.04e-07 | 11 | 29 | 3 | CID000003553 | |
| Drug | I-Q-S | 1.47e-06 | 156 | 29 | 5 | CID000003540 | |
| Drug | Sikvav | 3.69e-06 | 24 | 29 | 3 | CID005487517 | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; PC3; HT_HG-U133A | 4.29e-06 | 194 | 29 | 5 | 6667_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 4.62e-06 | 197 | 29 | 5 | 7500_UP | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.98e-06 | 200 | 29 | 5 | 5917_DN | |
| Drug | PDBu | 1.44e-05 | 249 | 29 | 5 | CID000037783 | |
| Drug | Calcort | 1.52e-05 | 38 | 29 | 3 | CID000026709 | |
| Drug | Ikvav | 1.52e-05 | 38 | 29 | 3 | CID000131343 | |
| Drug | 1-stearoyl-2-arachidonoyl-sn-glycerol | 1.78e-05 | 40 | 29 | 3 | CID000001398 | |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 4.37e-05 | 314 | 29 | 5 | CID000003542 | |
| Drug | kalinin | 4.66e-05 | 55 | 29 | 3 | CID000032518 | |
| Drug | CC270 | 5.76e-05 | 59 | 29 | 3 | CID006918852 | |
| Drug | LG 5 | 6.05e-05 | 60 | 29 | 3 | CID011840957 | |
| Drug | DB04780 | 6.16e-05 | 170 | 29 | 4 | CID005459389 | |
| Drug | taxol | 6.32e-05 | 560 | 29 | 6 | CID000004666 | |
| Drug | AC1L1ET5 | 7.70e-05 | 65 | 29 | 3 | CID000002936 | |
| Drug | BM165 | 8.55e-05 | 11 | 29 | 2 | CID003352881 | |
| Drug | 5152487; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.01e-04 | 193 | 29 | 4 | 896_UP | |
| Drug | 5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA | 1.03e-04 | 194 | 29 | 4 | 828_UP | |
| Drug | C-1b | 1.04e-04 | 72 | 29 | 3 | CID006102740 | |
| Drug | Methazolamide [554-57-4]; Up 200; 17uM; MCF7; HT_HG-U133A | 1.05e-04 | 195 | 29 | 4 | 6268_UP | |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; MCF7; HT_HG-U133A | 1.05e-04 | 195 | 29 | 4 | 2808_DN | |
| Drug | Oxybenzone [131-57-7]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 6469_DN | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 3382_UP | |
| Drug | Milrinone [78415-72-2]; Down 200; 19uM; PC3; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 5856_DN | |
| Drug | Isoetharine mesylate salt [7279-75-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 3451_UP | |
| Drug | Ethamsylate [2624-44-4]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 4399_UP | |
| Drug | Bretylium tosylate [61-75-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 6674_DN | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 5604_UP | |
| Drug | dysprosium | 1.13e-04 | 74 | 29 | 3 | CID000023912 | |
| Drug | A0395 | 1.18e-04 | 75 | 29 | 3 | CID009906466 | |
| Drug | MS-551 | 1.21e-04 | 13 | 29 | 2 | CID000004486 | |
| Drug | 2-amino-5-methylpyridine | 1.28e-04 | 77 | 29 | 3 | CID000015348 | |
| Drug | YIGSR | 1.38e-04 | 79 | 29 | 3 | CID000123977 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.59e-04 | 83 | 29 | 3 | CID011968896 | |
| Drug | dansyl-DAG | 1.63e-04 | 15 | 29 | 2 | CID000129493 | |
| Drug | RK-1409B | 1.63e-04 | 15 | 29 | 2 | CID003036125 | |
| Drug | 1-stearoyl-2-arachidonylglycerol | 1.63e-04 | 15 | 29 | 2 | CID006443869 | |
| Drug | NSC 714187 | 1.71e-04 | 85 | 29 | 3 | CID005288693 | |
| Drug | 1,2-dimethylhydrazine | 1.77e-04 | 86 | 29 | 3 | CID000001322 | |
| Drug | 5-hydroxydecanoate | 1.83e-04 | 87 | 29 | 3 | CID000001824 | |
| Drug | C-1A | 2.09e-04 | 91 | 29 | 3 | CID009543473 | |
| Drug | AC1L1JQC | 2.11e-04 | 17 | 29 | 2 | CID000005157 | |
| Drug | daphnoretin | 2.11e-04 | 17 | 29 | 2 | CID005281406 | |
| Drug | dipalmitin | 2.37e-04 | 18 | 29 | 2 | CID000068149 | |
| Drug | Cgp-42700 | 2.37e-04 | 18 | 29 | 2 | CID000188390 | |
| Drug | dihydrosterculic acid | 2.37e-04 | 18 | 29 | 2 | CID000160788 | |
| Drug | TAPP-Br | 2.64e-04 | 19 | 29 | 2 | CID000160326 | |
| Drug | sapintoxin A | 2.64e-04 | 19 | 29 | 2 | CID000108085 | |
| Drug | AC1L1KMJ | 3.07e-04 | 476 | 29 | 5 | CID000030956 | |
| Drug | KS-619-1 | 3.24e-04 | 21 | 29 | 2 | CID000128369 | |
| Drug | K-259-2 | 3.24e-04 | 21 | 29 | 2 | CID006438946 | |
| Drug | debromoaplysiatoxin | 3.24e-04 | 21 | 29 | 2 | CID000002967 | |
| Drug | broussochalcone A | 3.24e-04 | 21 | 29 | 2 | CID006438825 | |
| Drug | ALT-711 | 3.24e-04 | 21 | 29 | 2 | CID000216304 | |
| Drug | MDL 27,032 | 3.24e-04 | 21 | 29 | 2 | CID000163812 | |
| Drug | AC1L1C2F | 3.66e-04 | 110 | 29 | 3 | CID000001711 | |
| Drug | AC1L4NFY | 3.90e-04 | 23 | 29 | 2 | CID000160335 | |
| Drug | cholesterol sulfate | 3.96e-04 | 113 | 29 | 3 | CID000065076 | |
| Drug | genistein | 4.05e-04 | 1117 | 29 | 7 | CID005280961 | |
| Drug | methazolamide | 5.00e-04 | 26 | 29 | 2 | CID000004100 | |
| Drug | beta-tocopherol | 5.39e-04 | 27 | 29 | 2 | CID000008989 | |
| Drug | ilmofosine | 5.39e-04 | 27 | 29 | 2 | CID000055008 | |
| Drug | C15720 | 5.39e-04 | 27 | 29 | 2 | CID000003979 | |
| Drug | pseudohypericin | 5.39e-04 | 27 | 29 | 2 | CID005281751 | |
| Drug | nickel chloride | 5.57e-04 | 1178 | 29 | 7 | ctd:C022838 | |
| Drug | AC1L1JM9 | 5.69e-04 | 304 | 29 | 4 | CID000005103 | |
| Drug | bisindolylmaleimide II | 5.80e-04 | 28 | 29 | 2 | CID000002397 | |
| Drug | bisindolylmaleimide V | 5.80e-04 | 28 | 29 | 2 | CID000002400 | |
| Drug | aplysiatoxin | 5.80e-04 | 28 | 29 | 2 | CID000040465 | |
| Drug | HBDDE | 5.80e-04 | 28 | 29 | 2 | CID000003568 | |
| Drug | SC-10 | 5.80e-04 | 28 | 29 | 2 | CID000005175 | |
| Drug | NCDC | 5.80e-04 | 28 | 29 | 2 | CID000001583 | |
| Drug | 2,3-pentanedione | 5.83e-04 | 129 | 29 | 3 | ctd:C013186 | |
| Drug | AC1Q6DXY | 6.23e-04 | 29 | 29 | 2 | CID000003719 | |
| Drug | Polychlorinated biphenyls | 6.23e-04 | 29 | 29 | 2 | CID000006636 | |
| Drug | AC1L40MO | 6.37e-04 | 133 | 29 | 3 | CID000099067 | |
| Drug | NSC339555 | 6.37e-04 | 133 | 29 | 3 | CID000433902 | |
| Drug | dibutyryl cyclic 3',5'-AMP | 6.49e-04 | 561 | 29 | 5 | CID000002460 | |
| Drug | AC1Q5V5T | 6.65e-04 | 135 | 29 | 3 | CID000004701 | |
| Drug | gepirone | 6.67e-04 | 30 | 29 | 2 | CID000055190 | |
| Drug | Gf 109 | 6.67e-04 | 30 | 29 | 2 | CID000196144 | |
| Drug | AC1L3G0K | 6.67e-04 | 30 | 29 | 2 | CID000114822 | |
| Drug | 12-deoxyphorbol 13-phenylacetate | 6.67e-04 | 30 | 29 | 2 | CID000105100 | |
| Drug | N,n,n-tms | 7.12e-04 | 31 | 29 | 2 | CID006439410 | |
| Drug | trypanothione disulfide | 7.40e-04 | 140 | 29 | 3 | CID000115098 | |
| Drug | 0-to | 7.55e-04 | 141 | 29 | 3 | CID000002051 | |
| Drug | AC1L1E8B | 7.59e-04 | 32 | 29 | 2 | CID000002684 | |
| Drug | isovalerate | 7.86e-04 | 143 | 29 | 3 | CID000010430 | |
| Drug | CGS 9343B | 8.07e-04 | 33 | 29 | 2 | CID000065909 | |
| Drug | Argentine | 8.07e-04 | 33 | 29 | 2 | CID000442941 | |
| Drug | naphthalenesulfonamide | 8.07e-04 | 33 | 29 | 2 | CID000163571 | |
| Drug | AC1L1FGW | 8.07e-04 | 33 | 29 | 2 | CID000003231 | |
| Drug | DiC8 | 8.35e-04 | 146 | 29 | 3 | CID000001323 | |
| Drug | AC1NSKHR | 8.57e-04 | 34 | 29 | 2 | CID005311362 | |
| Drug | h x mg | 8.57e-04 | 34 | 29 | 2 | CID000001380 | |
| Disease | Glioblastoma Multiforme | 1.42e-04 | 111 | 27 | 3 | C1621958 | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 1.68e-04 | 21 | 27 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 3.00e-04 | 28 | 27 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | lung squamous cell carcinoma (is_marker_for) | 4.98e-04 | 36 | 27 | 2 | DOID:3907 (is_marker_for) | |
| Disease | candidiasis (implicated_via_orthology) | 7.45e-04 | 44 | 27 | 2 | DOID:1508 (implicated_via_orthology) | |
| Disease | visceral:subcutaneous adipose tissue ratio | 1.87e-03 | 70 | 27 | 2 | EFO_0004767 | |
| Disease | susceptibility to mumps measurement | 2.15e-03 | 75 | 27 | 2 | EFO_0008404 | |
| Disease | acne | 5.83e-03 | 125 | 27 | 2 | EFO_0003894 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CNDRGVCNNKKHCHC | 621 | Q99965 | |
| NEECDCGNKNECQFK | 401 | Q9Y3Q7 | |
| RCKDCGMNCHKQCKD | 571 | O95267 | |
| AQCAHGTCCQECKVK | 446 | P78325 | |
| CCDRAEDHACQNACK | 216 | O95980 | |
| CQKQCRDENGFKCHC | 31 | O60870 | |
| CSNCNANVHKGCKDA | 681 | Q8N1W1 | |
| RCKCGRQFCFNCGEN | 296 | Q9Y4X5 | |
| CCNQHDRCYETCGKS | 106 | Q9BZM1 | |
| CKDCRFNCHKRCAPK | 301 | Q15139 | |
| CQKHQCRRKCCPGNC | 476 | Q6ZNB6 | |
| GLKCRACGVNCHKQC | 526 | Q7LDG7 | |
| MVFCDKCNVCVHQAC | 216 | Q9NQC1 | |
| CNARCQEFGNCCKDF | 106 | P21128 | |
| KCTKCQCNGHADTCN | 2376 | Q7Z7M0 | |
| QCKDCKFNCHKRCAS | 301 | O94806 | |
| GRNSNACKKCNCNEH | 326 | P07942 | |
| CCDFCHNAFCKKCIL | 231 | P46100 | |
| DCNCSICKKKQNRHF | 171 | Q7Z7K6 | |
| CNDNTDGIHCEKCKN | 56 | Q13753 | |
| NCNKTNGQCHCKEFH | 2051 | Q9NYQ7 | |
| LGQFCCALHKACQSC | 721 | Q8TEX9 | |
| DRQCQDNKKCCVFSC | 51 | O95925 | |
| RCQTCKANLCHFCCQ | 146 | Q9H8W5 | |
| GNTCEACNCHNKAKD | 321 | P25391 | |
| QQKGCCQQKCCCQKQ | 91 | A0A286YFG1 | |
| CCKNCQFETAQKKCQ | 521 | P78536 | |
| QHKFICEQCGKCKCG | 176 | O43609 | |
| LGQHSCLRCKACFCD | 181 | Q9Y3S2 | |
| QHHCRKCGQAVCGKC | 311 | Q8IWB7 |